Company information
- Ticker
- PURE
- Country
- United States
- Sector
- Consumer Staples
- Industry
- Personal Care
PURE BIOSCIENCE Business Summary
PURE Bioscience, Inc. (PURE) operates as a biotechnology company focused on the development and commercialization of proprietary antimicrobial products utilizing its patented Silver Dihydrogen Citrate (SDC) technology. The company generates revenue primarily through the direct sale of SDC-based solutions, including PURE Hard Surface for food contact surface disinfection and PURE Control as a direct food-contact processing aid. Its business is segmented into food safety (targeting produce, dairy, and beverage processors), food transportation (sanitation for large trucking fleets), and restaurant chains. As of early 2026, PURE is positioning itself as a non-toxic, high-efficacy alternative to traditional chemical sanitizers, recently achieving significant market milestones with the adoption of PURE Control for commercial leafy green treatment. It competes directly with larger chemical and antimicrobial firms such as Sciessent, Microban (a subsidiary of RPM International), and Sika AG, maintaining a niche market position focused on the food-grade safety and environmental benefits of its ionic silver platform. The company’s leadership is currently led by Chief Executive Officer Robert Bartlett, who assumed the role in 2023 following a career as Chairman of Advanced Marketing Services. In November 2025, the executive team was restructured to promote Jeff Kitchell to President and Corporate Secretary, leveraging his 24-year tenure with the firm to oversee operational execution. Other key executives include Mark Elliott, Vice President of Finance and Principal Financial Officer; Tom Myers, Executive Vice President of Technology and Development; and Dolana Blount, who serves as Vice President of Operations and Regulatory Affairs. The Board of Directors is chaired by Ivan Chen, an attorney and entrepreneur with a background in M&A at eBay, and includes notable members such as Bernard Blotner, a former Senior Vice President at Morgan Stanley Wealth Management, and Tom Y. Lee, the company’s former CEO and current President of MicroTube, Inc.